GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,288,345 | +204.2% | 3,275,192 | +128.1% | 0.01% | +125.0% |
Q2 2023 | $2,067,172 | -22.6% | 1,435,557 | +12.9% | 0.00% | -20.0% |
Q1 2023 | $2,670,656 | +86.0% | 1,271,760 | +0.1% | 0.01% | +66.7% |
Q4 2022 | $1,436,165 | -32.4% | 1,270,328 | -2.4% | 0.00% | -40.0% |
Q3 2022 | $2,123,000 | +26.1% | 1,302,122 | +1.4% | 0.01% | +25.0% |
Q2 2022 | $1,684,000 | -17.4% | 1,284,481 | +1.5% | 0.00% | 0.0% |
Q1 2022 | $2,038,000 | -21.1% | 1,265,820 | +1.5% | 0.00% | -20.0% |
Q4 2021 | $2,582,000 | -47.8% | 1,247,401 | -2.1% | 0.01% | -50.0% |
Q3 2021 | $4,943,000 | +21.3% | 1,273,957 | +0.1% | 0.01% | +11.1% |
Q2 2021 | $4,074,000 | +53.7% | 1,273,157 | +4.2% | 0.01% | +50.0% |
Q1 2021 | $2,651,000 | +8.0% | 1,221,984 | +11.5% | 0.01% | -14.3% |
Q4 2020 | $2,454,000 | -11.2% | 1,095,975 | +5.8% | 0.01% | -12.5% |
Q3 2020 | $2,765,000 | -10.7% | 1,035,821 | +2.3% | 0.01% | -20.0% |
Q2 2020 | $3,098,000 | +82.9% | 1,012,430 | +17.1% | 0.01% | +42.9% |
Q1 2020 | $1,694,000 | – | 864,275 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |